Literature DB >> 30417404

Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.

R Horn1, N J Bamford2, T Afonso3, M Sutherland4, J Buckerfield5, R H H Tan6,7, C J Secombe8, A J Stewart1, F R Bertin1.   

Abstract

BACKGROUND: Pituitary pars intermedia dysfunction (PPID) is a commonly described endocrine disorder in higher latitudes of the Northern hemisphere but the description of the disease at lower latitudes and in the Southern hemisphere is limited.
OBJECTIVES: Document the clinical features of PPID at different Australian latitudes and climates, and investigate factors associated with survival, laminitis and insulin dysregulation (ID). STUDY
DESIGN: Retrospective study of 274 equids from eight institutions across Australia.
METHODS: A diagnosis of PPID was based on endogenous ACTH, overnight dexamethasone suppression test, thyrotropin-releasing hormone stimulation test or necropsy. Clinical and clinicopathologic characteristics of PPID and therapeutic responses were investigated. Laminitis was diagnosed by radiographic or histologic changes and ID was diagnosed based on endogenous insulin, an oral glucose test or a 2-step insulin-response test.
RESULTS: Being a pony, having a higher body condition score and pergolide administration were associated with survival. The clinical presentation of PPID changed with latitude and climate, with anhidrosis and polyuria/polydipsia more commonly recognised at lower latitudes. Laminitis was diagnosed in 89.9% of cases and ID was present in 76.5% of cases in which they were investigated. MAIN LIMITATIONS: Despite the sample size, the lack of uniform testing at all locations (primary or referral cases) and the incompleteness of data sets limited the power of the statistical analyses.
CONCLUSIONS: PPID can present with variable signs at different latitudes and climates, and ID should be investigated in equids diagnosed with PPID. Adequate body condition and administration of pergolide are fundamental in PPID management.
© 2018 EVJ Ltd.

Entities:  

Keywords:  anhidrosis; endocrinology; epidemiology; equine metabolic syndrome; horse; metabolic disease

Mesh:

Substances:

Year:  2018        PMID: 30417404     DOI: 10.1111/evj.13041

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  12 in total

1.  Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol.

Authors:  Elizabeth Hodge; Alycia Kowalski; Catherine Torcivia; Sue Lindborg; Darko Stefanovski; Kelsey Hart; Nicholas Frank; Andrew van Eps
Journal:  J Vet Intern Med       Date:  2019-08-20       Impact factor: 3.333

2.  Immunoreactive insulin stability in horses at risk of insulin dysregulation.

Authors:  Dakota H Leschke; Genevieve S Muir; Jack K Hodgson; Mitchell Coyle; Remona Horn; François-René Bertin
Journal:  J Vet Intern Med       Date:  2019-10-16       Impact factor: 3.333

3.  The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.

Authors:  Ke Hu; Allison J Stewart; Ka Y Yuen; Sophia Hinrichsen; Elizabeth L Dryburgh; François-René Bertin
Journal:  J Vet Intern Med       Date:  2020-04-07       Impact factor: 3.333

4.  Equine pituitary pars intermedia dysfunction: Identifying research priorities for diagnosis, treatment and prognosis through a priority setting partnership.

Authors:  Rebecca C Tatum; Cathy M McGowan; Rachel S Dean; Joanne L Ireland
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

5.  Exodontia associated bacteremia in horses characterized by next generation sequencing.

Authors:  Kile S Townsend; Philip J Johnson; Alison M LaCarrubba; Lynn M Martin; Aaron C Ericsson
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

6.  Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses.

Authors:  Remona Horn; Allison J Stewart; Karen V Jackson; Elizabeth L Dryburgh; Carlos E Medina-Torres; François-René Bertin
Journal:  J Vet Intern Med       Date:  2020-12-24       Impact factor: 3.175

7.  Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses.

Authors:  Yan Ning Kam; Kelly McKenzie; Mitchell Coyle; François-René Bertin
Journal:  J Vet Intern Med       Date:  2021-10-13       Impact factor: 3.333

8.  Short-Term Effects of Temperature and Thyrotropin-Releasing Hormone Stimulation on Adrenocorticotropin Stability in Horses.

Authors:  Sophia L Hinrichsen; Ka Y Yuen; Elizabeth L Dryburgh; François-René Bertin; Allison J Stewart
Journal:  Animals (Basel)       Date:  2022-01-28       Impact factor: 2.752

9.  Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.

Authors:  Remona Horn; François-René Bertin
Journal:  J Vet Intern Med       Date:  2019-09-09       Impact factor: 3.333

10.  Effect of early or late blood sampling on thyrotropin releasing hormone stimulation test results in horses.

Authors:  Kristen Thane; Cassandra Uricchio; Nicholas Frank
Journal:  J Vet Intern Med       Date:  2022-01-20       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.